[EN] COMPOUNDS AS CCR2 MODULATORS<br/>[FR] COMPOSÉS UTILISÉS COMME MODULATEURS DE CCR2
申请人:[en]ARIA PHARMACEUTICALS, INC.
公开号:WO2023081666A1
公开(公告)日:2023-05-11
The present disclosure relates generally to small molecule modulators of chemotactic cytokines (chemokine) receptors CCR2, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof.